TotalMarketCap

Novartis

NVSNYSE SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$273.076 B

$143.11 -0.12%

Close of 9 Oct 2026

As of 9 Oct 2026, Novartis (NVS) has a market capitalization of $273.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,908,151,679

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #3AbbVieABBV$481.4B
  2. #4Merck & Co.MRK$351.3B
  3. #5NovartisNVS$273.1B
  4. #6AstrazenecaAZN$246.2B
  5. #7Abbott LaboratoriesABT$170.4B

What if Novartis were worth as much as…

Open the what-if tool →

Gold $29.1T

$15,230.37

Per share 106× higher

Bitcoin $1.66T

$870.26

Per share 6.08× higher

Nvidia $5.55T

$2,910.97

Per share 20.3× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Novartis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.